Bayer AG and uniQure: Leading the Charge in AAV Vector Manufacturing Innovations
The Adeno-Associated Virus (AAV) vectors manufacturing market has seen significant advancements due to their growing applications in gene therapy and vaccine development. AAVs are recognized for their minimal pathogenicity, broad tissue tropism, and ability to establish long-term gene expression, making them a cornerstone in genetic disorder treatments. As the market for AAV vectors continues...
0 Comments
0 Shares
490 Views
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek